Study Summary
This trial will compare two imaging tests to measure prostate cancer progression and collect blood samples for future research.
- Prostate Cancer
Treatment Effectiveness
Phase-Based Effectiveness
Study Objectives
1 Primary · 1 Secondary · Reporting Duration: Immediately after biopsy.
Trial Safety
Phase-Based Safety
Awards & Highlights
Trial Design
1 Treatment Group
Combined MRI and micro-ultrasound guided prostate biopsy.
1 of 1
Experimental Treatment
210 Total Participants · 1 Treatment Group
Primary Treatment: Combined MRI and micro-ultrasound guided prostate biopsy. · No Placebo Group · N/A
Trial Logistics
Trial Timeline
Who is running the clinical trial?
Eligibility Criteria
Age 18+ · Male Participants · 0 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Frequently Asked Questions
Are there any vacancies remaining for individuals interested in participating in this clinical trial?
"As evidenced by clinicaltrials.gov, this study is currently recruiting patients. The trial was first advertised on January 1st 2023 and has been revised most recently on the 12th of January 2023." - Anonymous Online Contributor
How many participants are allowed to join this experiment?
"Affirmative. The information available on clinicaltrials.gov confirms that this experiment is actively searching for participants and was published on January 1st 2023, with the last update being made on December 12th of the same year. 210 volunteers need to be recruited from a single site." - Anonymous Online Contributor